"I wouldn't be surprised if COURAGE, as designed, is a negative trial, " GreggStone, director of cardiovascular research and education at Columbia University Medical Center, said two weeks ago.
"I wouldn't be surprised if COURAGE, as designed, is a negative trial, " says GreggStone, director of cardiovascular research and education at Columbia University Medical Center, who has conducted major clinical trials of Boston Scientific's stent.